Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, November 2003, p. 1129-1135, Vol. 10, No. 6
1071-412X/03/$08.00+0 DOI: 10.1128/CDLI.10.6.1129-1135.2003
TB Research Group,1 TSE Molecular Biology Group, Veterinary Laboratories Agency, Addlestone, Surrey KT15 3NB,2 Institute for Animal Health, Compton, Berkshire RG20 7NN, United Kingdom3
Received 2 April 2003/ Returned for modification 23 May 2003/ Accepted 23 July 2003
This report describes the presence and activity of 1,25-dihydroxyvitamin D3 (1,25-D3) in experimental bovine tuberculosis. Animals that went on to develop tuberculous lesions exhibited a rapid transient increase in serum 1,25-D3 within the first 2 weeks following infection with Mycobacterium bovis. 1,25-D3-positive mononuclear cells were later identified in all tuberculous granulomas by immunohistochemical staining of postmortem lymph node tissue. These results suggest a role for 1,25-D3 both at the onset of infection and in the development of the granuloma in these infected animals. Using a monoclonal antibody to the vitamin D receptor (VDR) as a VDR agonist, we confirmed that activation of the vitamin D pathway profoundly depresses antigen-specific, but not mitogenic, bovine peripheral blood T-cell responses (proliferation and gamma interferon production). Investigation of the mechanism of this suppression showed that the VDR antibody modified the expression of CD80 by accessory cells, such that a significant positive correlation between T-cell proliferation and accessory cell CD80 emerged.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |